Quality Assurance (QA) and Quality Control (QC) are essential components of ensuring the quality and integrity of clinical research trials conducted under Good Clinical Practice (GCP) guidelines. While these terms are sometimes used interchangeably, it is important to understand their distinctions and the specific protocols associated with each area.

What is Same and Different between QA and QC in Clinical Research?
To begin, let’s take a moment to define each term for clarity:

Quality Control (QC) is defined as an aggregate of activities designed to verify that clinical data are generated, collected, handled, analyzed, and reported according to protocol, Standard Operating Procedures (SOPs), and Good Clinical Practice (GCP) guidelines. In clinical research, this is used to ensure the protection of the patients and participants by the reduction of risk, reliability of data collected and assurance of consistent internal processes. QC focuses on the testing of products to meet established quality standards. Examples of QC include:

  • Review and inquiry of the protocol by the Institutional Review Board (IRB), an ethics review committee designed to ensure the safety of the human subject within the clinical trial domain,
  • Ensuring proper execution of the Informed Consent for all subjects enrolled at a site into the clinical trial.
  • Select a random product, test it, and rank it on a chart. The testing parameters should be measurable and quantifiable. The chart should determine if the product meets the set quality standards or shows how much it varies if it does not.
  • In manufacturing, this could be testing different stages of production, from raw material to the final output, to detect if dangerous microbiological elements occur could require the need to change packaging and storage conditions.

    Quality Assurance (QA) is defined as a planned, systematic, and independent evaluation of trial ‐related activities and documents to verify data has been generated, collected, handled, analyzed, and reported according to protocol, SOPs, and GCPs. The goal is to minimize the risk of errors, bias, and fraud, to ensure trial results are trustworthy and help support clinical decision-making. Examples of QC include:

    • Verification of data writing on source documents or in medical histories against what is entered in the electronic data capture database (EDC) of the sponsor.
    • A sponsor hires a clinical trial monitor to go to a clinical site every month to review materials generated through a clinical trial that is enrolling.
    • In the laboratory, regularly calibrate equipment and machines before starting experiments or tests.
    The Similarities:
    QC and QA both fall under Quality Management (QM). QM is defined by the National Institutes of Health (NIH, 2023) as “the overall process of establishing and ensuring the quality of processes, data, and documentation associated with clinical research activities.” It encompasses both quality control (QC) and quality assurance (QA) activities. Most organizations create a Quality Management System (QMS) defined as a formalized system that documents processes, procedures, and responsibilities for achieving quality policies and objectives. A QMS helps coordinate and direct an organization’s activities to meet customer and regulatory requirements and improve its effectiveness and efficiency on a continuous basis.

    QA and QC are both concerned with:

    •  Eliminating defects within a process or system
    • Mitigating risk to provide safety for the environment and/or human
    • They share the same goals as the stakeholders under the QMS umbrella
    • They both ensure a product or service meets a certain standard of quality
    Quality Management Principles Graph
    The Differences:
    Many people use the terms QA and QC interchangeably as they have related concepts. Outlined below are some simple ways to keep them separate:

    Table explaining the differences of QA and QC

    Simply put, within the sphere of GCP, QC is a subset of QA. QA is extensive and evaluates the whole process from making the product to its use, while QC is more focused in the inspection process to validate quality and identify problems or issues. QA shows the overall process from prevention to corrective action, whereas QC points out the problem.

    Examples:
    A few examples in clinical research of how regulations provide guidance are:

    1. ICH E6(R2) GCP Guidelines have “Quality” Guidance we recognize:
    • All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation, and verification (2.10)
    • Systems with procedures that assure the quality of every aspect of the trial should be implemented (2.13)
    • Quality control (QC) should be applied to each stage of data handling to ensure that all data are reliable and have been processed correctly (5.1.3)
    1. ISO 9001:2015 is another example of one of the most recognized and implemented quality management systems in the world.
    2. The United States Food and Drug Administration also defines “Quality” regulations and guidance under Investigator and Sponsor responsibilities
    Conclusion:
    In conclusion, Quality Assurance (QA) and Quality Control (QC) are two distinct but interrelated aspects of ensuring quality in clinical research trials and Good Clinical Practice (GCP). While they share similarities and both fall under the umbrella of Quality Management (QM), they have different orientations and functions.

    QC is focused on the inspection and testing of products or processes to meet established quality standards. It aims to identify issues, validate quality, and ensure reliable outcomes. Examples of QC activities include reviewing protocols, ensuring proper execution of informed consent, and conducting random product testing.

    FDAQRC can help with any step of your Quality Management process. We have GCP experts on hand who value Quality standards and are experienced with Quality Assurance, Quality Control, and Quality Improvement.

    This insight was provided by FDAQRC’s Auditor, Amy Fox.

    Amy Fox is a full time Auditor for FDAQRC with over 20 years of experience in clinical trial operations and regulatory compliance. She holds her Certified Clinical Research Coordinator (CCRP) with ACRP. Her areas of expertise include GCP and early phase human pharmaceutical clinical research.

    image
    DISCOVER MORE